Switch of FANCL, a key FA-BRCA component, between tumor suppressor and promoter by alternative splicing.
Comment on: Panneerselvam J, et al. Cell Cycle 2012; 11:2947-55.
Hormel Institute, University of Minnesota, Austin, MN, USA.
Chengfu
C
Yuan
Ningzhi
N
Xu
Joshua
J
Liao
D000818:Animals; D005199:Fanconi Anemia / Q000378:metabolism*; D052240:Fanconi Anemia Complementation Group L Protein / Q000378:metabolism*; D006801:Humans; D008297:Male; D001749:Urinary Bladder Neoplasms / Q000378:metabolism*
D052240:Fanconi Anemia Complementation Group L Protein